Z-1660-2023 Class II Ongoing
FDA device recall Z-1660-2023 was initiated by Maquet Medical Systems USA on May 18, 2023 and is designated Class II. Reason for recall: Product packaging may exhibit small pinholes which may not be visible to the unaided eye, compromising the sterile barrier of the packaging. Exposure to non-sterile device may result in inflammation… The recall status is ongoing. Affected quantity: 0 (US).
Recall details
- Product Type
- Devices
- Report Date
- Jun 7, 2023
- Initiation Date
- May 18, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 0 (US)
Product description
QUADROX -i Neonatal, Oxygenator used during cardiopulmonary bypass Model Item No. HMO 10000-USA 701070412 HMO 11000-USA 701070416
Reason for recall
Product packaging may exhibit small pinholes which may not be visible to the unaided eye, compromising the sterile barrier of the packaging. Exposure to non-sterile device may result in inflammation, infection, sepsis, and ischemia.
Distribution pattern
Nationwide domestic distribution
Code information
Model Item No. UDI HMO 10000-USA 701070412 4058863154473 HMO 11000-USA 701070416 4058863154558 All lots
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1660-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026